-
Abstract: Acromegaly is a chronic, progressive endocrine disorder with a hidden onset, often accompanied by various severe cardiovascular conditions. We present one case of acromegaly where secondary hypertension was the primary manifestation upon admission to our department. Our objective is to investigate the features of secondary hypertension in acromegaly patients and provide a clinical basis for treatment.
-
Key words:
- secondary hypertension /
- acromegaly
-
-
[1] Kasuki L, Rocha PDS, Lamback EB, et al. Determinants of morbidities and mortality in acromegaly[J]. Arch Endocrinol Metab, 2019, 63(6): 630-637. doi: 10.20945/2359-3997000000193
[2] Puglisi S, Terzolo M. Hypertension and acromegaly[J]. Endocrinol Metab Clin North Am, 2019, 48: 779-793. doi: 10.1016/j.ecl.2019.08.008
[3] 谭惠文, 覃萌, 余叶蓉, 等. 肢端肥大症诊断和药物治疗进展—2021年《垂体协会肢端肥大症诊治指南更新》解读[J]. 中国全科医学, 2021, 24(27): 3397-3403. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202127002.htm
[4] 周沫, 陈月, 钱文杰, 等. 肢端肥大症患者心血管疾病风险血清标志物的变化及长效奥曲肽治疗对其水平的影响[J]. 解放军医学杂志, 2022, 47(1): 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202201010.htm
[5] Giustina A, Barkhoudarian G, Beckers A, et al. Multidisciplinary management of acromegaly: A consensus[J]. Rev Endocr Metab Disord, 2020, 21(4): 667-678. doi: 10.1007/s11154-020-09588-z
[6] Fleseriu M, Langlois F, Lim DST, et al. Acromegaly: pathogenesis, diagnosis, and management[J]. Lancet Diabetes Endocrinol, 2022, 10(11): 804-826. doi: 10.1016/S2213-8587(22)00244-3
[7] Giustina A, Barkan A, Beckers A, et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update[J]. J Clin Endocrinol Metab, 2020, 105(4): dgz096.
[8] Cadena-Obando DA, Remba-Shapiro I, Abreu-Rosario CG, et al. Acromegaly and it's cardiovascular implications[J]. Rev Med Inst Mex Seguro Soc, 2021, 59(1): 73-80.
[9] Kamenicky P, Maione L, Chanson P. Cardiovascular complications of acromegaly[J]. Ann Endocrinol(Paris), 2021, 82(3-4): 206-209. doi: 10.1016/j.ando.2020.03.010
[10] Hong S, Kim KS, Han K, et al. Acromegaly and cardiovascular outcomes: a cohort study[J]. Eur Heart J, 2022, 43(15): 1491-1499. doi: 10.1093/eurheartj/ehab822
[11] Giantini-Larsen AM, Uribe-Cardenas R, Juthani RG. Acromegaly: medical and surgical considerations[J]. Otolaryngol Clin North Am, 2022, 55(2): 331-341. doi: 10.1016/j.otc.2021.12.007
[12] Lim DST, Fleseriu M. Personalized medical treatment of patients with acromegaly: a review[J]. Endocr Pract, 2022, 28(3): 321-332. doi: 10.1016/j.eprac.2021.12.017
[13] 赵力博, 徐伟豪, 钱小顺, 等. 阻塞性睡眠呼吸暂停相关高血压的研究进展[J]. 解放军医学院学报, 2021, 42(4): 451-455. https://www.cnki.com.cn/Article/CJFDTOTAL-JYJX202104017.htm
-